Zobrazeno 1 - 10
of 26
pro vyhledávání: '"P G Pitsakis"'
Autor:
Susan R. Altork, Karam Mounzer, Guibin Yang, P G Pitsakis, Peter D. Katsikis, Jeffrey M. Jacobson, John D. Altman, Constantinos Petrovas, Yvonne M. Mueller
Publikováno v:
Apoptosis. 12:2175-2186
We have recently provided data suggesting a potential role for mitochondria and Bcl-2-family molecules in apoptosis sensitivity of HIV-specific CD8+ T cells. Here, we report on the role of filamentous (F) actin in this process. Disruption of actin by
Autor:
Phyllis L. May, Matthew E. Levison, Pamela Adams, Sandeep K. Pradhan, Christopher L. Emery, P G Pitsakis, George A. Jacoby, Yamini V. Mailapur
Publikováno v:
Clinical Infectious Diseases. 35:1551-1554
Although the production of extended-spectrum beta-lactamases (ESBLs) by Klebsiella pneumoniae and Escherichia coli is an emerging problem, limited data are available regarding the frequency of ESBL production in other organisms. We provide the only d
Autor:
Mary Schwartz, Phyllis L. May, Matthew E. Levison, Caroline C. Johnson, Linda A. Slavoski, P G Pitsakis, Andrew L. Shur
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 21:169-173
The activity of RP 59500 (quinupristin/dalfopristin) was evaluated in vitro against antibiotic-resistant strains of Streptococcus pneumoniae (N = 15) and Enterococcus spp. (N = 43). By broth dilution MIC tests RP 59500 was highly active against penic
Autor:
Lawrence L. Livornese, Marla Gold, P G Pitsakis, S. Taylor, Matthew E. Levison, Caroline C. Johnson
Publikováno v:
Journal of Antimicrobial Chemotherapy. 35:765-773
Cefepime is a broad-spectrum cephalosporin that is reported to have enhanced activity against ceftazidime-resistant Gram-negative bacilli. In this study the effects of varying inoculum size on in-vitro susceptibility to cefepime and other selected an
Publikováno v:
Journal of Antimicrobial Chemotherapy. 32:577-585
The antimicrobial activities of two synthetic magainins, MSI 94 and MSI 93, were investigated in vitro against 20 clinical isolates each of Pseudomonas aeruginosa and Enterococcus faecium. The ranges of the MICs of both agents were 6.25-50 mg/L for P
Publikováno v:
Journal of the American Geriatrics Society. 44:293-295
OBJECTIVE: To determine whether treatment of asymptomatic bacteriuria in older ambulatory women affects the subsequent development of symptoms of urinary tract infection. DESIGN: A controlled clinical trial. PARTICIPANTS: Older women not having urina
Vancomycin-resistant enterococci have become important nosocomial pathogens in many institutions. The gastrointestinal tract of susceptible hosts serves as the likely reservoir from which the organism is disseminated. To study factors promoting colon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9b0c6f6a70ba8a53889f94b312ab7f
https://europepmc.org/articles/PMC163361/
https://europepmc.org/articles/PMC163361/
Autor:
A J Osborne, Lawrence L. Livornese, M S Whitman, P G Pitsakis, Matthew E. Levison, A Zausner, Caroline C. Johnson
Publikováno v:
Antimicrobial agents and chemotherapy. 37(10)
We compared ciprofloxacin, rifampin, and gentamicin treatments, alone and in combination, for 5 days in the therapy of experimental aortic valve endocarditis in rats caused by a clinical isolate of vancomycin-resistant Enterococcus faecium. The MICs
Ramoplanin, a new lipoglycodepsipeptide antibiotic, was uniformly active against 65 strains of enterococci, including strains highly resistant to vancomycin, penicillin G, and gentamicin. MBCs were usually within a fourfold dilution of the MICs. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de73dc0abdf553b3ad032bf6d15f907
https://europepmc.org/articles/PMC245501/
https://europepmc.org/articles/PMC245501/
Autor:
P G Pitsakis, Phyllis L. May, Barbara Romanowski, Lawrence L. Livornese, Susan Dias, Caroline C. Johnson, Donald Kaye, Carol Samel, Gail Woods, Shirley Taylor, Matthew E. Levison
Publikováno v:
Annals of internal medicine. 117(2)
To describe an epidemic of vancomycin-resistant Enterococcus faecium causing bacteremia and bacteriuria, to identify the source of infection, to delineate risk factors associated with acquisition of the organism, and to determine antibiotic sensitivi